FINLAND
Regulatory and Ethical Procedures
Before a clinical trial can commence, it has to be approved by the Ethics Committee of the Ministry of Social Affairs and Health. Good Clinical Practice and the Declaration of Helsinki must be observed.

The National Agency for Medicine (NAM) is responsible for overseeing clinical trials and carrying out inspections. Prior to conducting a clinical trial, the manufacturer of a medicinal product, the applicant for (or the holder of) a marketing authorisation or the investigator performing the trial must notify the National Agency for Medicine 60 days before the intended start of the trial. The notification has to be accompanied by relevant documents including the trial protocol and the opinion of the Ethics Committee.
Health Care System
Finland's health care system is funded for the most part by taxes, but there is also a private health care system as well as a mandatory health insurance policy scheme.
Authorities
National Agency for Medicine (NAM)